Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR

被引：0
作者：
Tao Li
Qi Xie
Yang-Yang Fang
Yi Sun
Xiao Ming Wang
Zhu Luo
Gui-Ling Yan
Jian-Bo He
Xiao-Qun Zheng
机构：
[1] The Second Affiliated and Yuying Children’s Hospital of Wenzhou Medical University,Department of Laboratory Medicine
[2] Wenzhou Medical University,School of Laboratory Medicine and Life Sciences, The Key Laboratory of Laboratory Medicine
[3] Ministry of Education of China,Department of Respiratory Medicine
[4] The Second Affiliated and Yuying Children’s Hospital of Wenzhou Medical University,undefined
来源：
BMC Cancer | / 23卷
关键词：
CYFRA 21 − 1; Ki67; NSCLC; Wild-type EGFR; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value [J].
Garcia-Valdecasas Gayo, Sonsoles ;
Ruiz-Alvarez, Maria Jesus ;
Gonzalez-Gay, Daniel ;
Ramos-Corral, Raquel ;
Marquez-Lietor, Eva ;
Del Amo, Nazaret ;
Plata, Maria del Carmen ;
Guillen-Santos, Raquel ;
Arribas, Ignacio ;
Cava-Valenciano, Fernando .
ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2020, 1 (04)
[42]   Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced/metastatic disease [J].
Sozutek, Didem ;
Yanik, Serdar ;
Akkoca, Ayse Neslin ;
Sozutek, Alper ;
Ozdemir, Zeynep Tuba ;
Avsar, Cigdem Usul ;
Gunaldi, Meral ;
Sahin, Berksoy ;
Doron, Figen .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (07) :1914-1922
[43]   The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients [J].
Dal Bello, M. G. ;
Filiberti, R. A. ;
Alama, A. ;
Orengo, A. M. ;
Mussap, M. ;
Coco, S. ;
Vanni, I. ;
Boccardo, S. ;
Rijavec, E. ;
Genova, C. ;
Biello, F. ;
Barletta, G. ;
Rossi, G. ;
Tagliamento, M. ;
Maggioni, C. ;
Grossi, F. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
[44]   Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial [J].
Duan, Jian-Chun ;
Wang, Zhi-Jie ;
Lin, Lin ;
Li, Jun-Ling ;
Wang, Yan ;
Bai, Hua ;
Hu, Xing-Sheng ;
Liu, Yu-Tao ;
Hao, Xue-Zhi ;
Wang, Hong-Yu ;
Wan, Rui ;
Wang, Xin ;
Wang, Jie .
INVESTIGATIONAL NEW DRUGS, 2019, 37 (04) :731-737
[45]   Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial [J].
Jian-Chun Duan ;
Zhi-Jie Wang ;
Lin Lin ;
Jun-Ling Li ;
Yan Wang ;
Hua Bai ;
Xing-Sheng Hu ;
Yu-Tao Liu ;
Xue-Zhi Hao ;
Hong-Yu Wang ;
Rui Wan ;
Xin Wang ;
Jie Wang .
Investigational New Drugs, 2019, 37 :731-737
[46]   FINAL RESULTS OF CTONG 0806: A PHASE II TRIAL COMPARING PEMETREXED WITH GEFITINIB AS SECOND-LINE TREATMENT OF ADVANCED NON-SQUAMOUS NSCLC PATIENTS WITH WILD-TYPE EGFR [J].
Zhou, Qing ;
Cheng, Ying ;
Zhao, Ming-Fang ;
Yang, Jin-Ji ;
Yan, Hong-Hong ;
Zhang, Li ;
Song, Yong ;
Chen, Jian-Hua ;
Feng, Wei-Neng ;
Xu, Chong-Rui ;
Wu, Yi-Long .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 :S194-S195
[47]   Phase I/II Study of Intermitted Erlotinib in Combination with Docetaxel in Patients with Recurrent NSCLC with Wild-Type EGFR: WJOG 4708L [J].
Kimura, T. ;
Kawaguchi, T. ;
Kudoh, S. ;
Chiba, Y. ;
Yoshioka, H. ;
Watanabe, K. ;
Kijima, T. ;
Kogure, Y. ;
Oguri, T. ;
Yoshimura, N. ;
Niwa, T. ;
Kasai, T. ;
Hayashi, H. ;
Ono, A. ;
Tanaka, H. ;
Yano, S. ;
Nakamura, S. ;
Yamamoto, N. ;
Nakanishi, Y. ;
Nakagawa, K. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S2129-S2129
[48]   The prognostic significance of p53, p27kip1, p21waf1, HER-2/neu, and ki67 proteins expression in gastric cancer:: A clinicopathological and lmmunohistochemical study of 121 Arab patients [J].
Al-Moundhri, MS ;
Nirmala, V ;
Al-Hadabi, I ;
Al-Mawaly, K ;
Burney, I ;
Al-Nabhani, M ;
Thomas, V ;
Ganguly, SS ;
Grant, C .
JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (04) :243-252
[49]   Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy [J].
Gauthe, Mathieu ;
Richard-Molard, Marion ;
Rigault, Eugenie ;
Buecher, Bruno ;
Mariani, Pascale ;
Bellet, Dominique ;
Cacheux, Wulfran ;
Lievre, Astrid .
BMC CANCER, 2018, 18
[50]   Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy [J].
Mathieu Gauthé ;
Marion Richard-Molard ;
Eugénie Rigault ;
Bruno Buecher ;
Pascale Mariani ;
Dominique Bellet ;
Wulfran Cacheux ;
Astrid Lièvre .
BMC Cancer, 18
12345